Yep anyone who made the choice to ride out the proverbial post adcom storm will be far better served not even worrying about the current share price and market malaise.
Eventually IPCI's earnings will post around mid October and if they are in fact close to attaining positive net income and making progress on Rexista...those next 2 already partnered with Mallinkrodt ANDA's will become huge future/pending catalysts that may finally begin attracting institutional support.
I personally don't believe for a single second that Dr. Odidi is folding up shop and going home...but for sure we're gonna be riding this post adcom storm for several months before finding out how well Dr. Odidi rises to the challenge.
I still think his nPODDS and PODRAS delivery technologies stand a good chance of becoming a major driving force in the entire global opioid landscape...but only if/when Dr. Odidi starts accepting the fact that in order to unlock and fulfill his dream he needs to align with and bring in the appropriate entities to help him!
News 
Market Data 
Discover 
